Re: dys
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: dys
Regarding our cash, I met recently with the board of directors and we decided not to pay out a dividend this period. We’ll revisit this issue regularly but for now I think we can put that cash to much better use in growing the company, as I hope to show you later this year.
I think it's about as late in the year as you can get.
Unless, he meant fiscal year, then he has 5 more months.
Be well
Loading...
Loading...
New Message
Please
login
to post a reply